Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population.

Marcus SchmidtVeronika Weyer-ElberichJan G HengstlerAnne-Sophie HeimesKatrin AlmstedtAslihan Gerhold-AyAntje LebrechtMarco J BattistaAnnette HasenburgUgur SahinKonstantine T KalogerasPirkko-Liisa Kellokumpu-LehtinenGeorge FountzilasRalph M WirtzHeikki Joensuu

Published in: Breast cancer research : BCR (2018)

The study reports retrospective biomarker analyses in the prospective FinHer trial and the prospective HE10/97 trial. ISRCTN76560285 . Registered on 18 March 2005. ACTRN12611000506998 . Registered on 16 May 2011.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
early breast cancer
open label
randomized controlled trial
case report
emergency department
peripheral blood